JP2009521228A5 - - Google Patents

Download PDF

Info

Publication number
JP2009521228A5
JP2009521228A5 JP2008547637A JP2008547637A JP2009521228A5 JP 2009521228 A5 JP2009521228 A5 JP 2009521228A5 JP 2008547637 A JP2008547637 A JP 2008547637A JP 2008547637 A JP2008547637 A JP 2008547637A JP 2009521228 A5 JP2009521228 A5 JP 2009521228A5
Authority
JP
Japan
Prior art keywords
well
lower chamber
cells
endothelial cells
porous membrane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008547637A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009521228A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/049128 external-priority patent/WO2007076061A1/en
Publication of JP2009521228A publication Critical patent/JP2009521228A/ja
Publication of JP2009521228A5 publication Critical patent/JP2009521228A5/ja
Pending legal-status Critical Current

Links

JP2008547637A 2005-12-21 2006-12-21 単球の樹状細胞への分化を促進する多孔質膜デバイス Pending JP2009521228A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75203305P 2005-12-21 2005-12-21
PCT/US2006/049128 WO2007076061A1 (en) 2005-12-21 2006-12-21 A porous membrane device that promotes the differentiation of monocytes into dendritic cells

Publications (2)

Publication Number Publication Date
JP2009521228A JP2009521228A (ja) 2009-06-04
JP2009521228A5 true JP2009521228A5 (enExample) 2012-04-12

Family

ID=37963795

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008547637A Pending JP2009521228A (ja) 2005-12-21 2006-12-21 単球の樹状細胞への分化を促進する多孔質膜デバイス

Country Status (9)

Country Link
US (2) US20070178076A1 (enExample)
EP (2) EP1963491B1 (enExample)
JP (1) JP2009521228A (enExample)
AT (2) ATE495238T1 (enExample)
AU (1) AU2006330951B2 (enExample)
CA (2) CA2634119C (enExample)
DE (1) DE602006019638D1 (enExample)
IL (1) IL192090A (enExample)
WO (1) WO2007076061A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7855074B2 (en) 2004-04-28 2010-12-21 Vaxdesign Corp. Artificial immune system: methods for making and use
US7785806B2 (en) 2004-04-28 2010-08-31 Vaxdesign Corporation Method for determining the immunogenicity of an antigen
US8298824B2 (en) 2004-04-28 2012-10-30 Sanofi Pasteur Vaxdesign Corporation Methods of evaluating a test agent in a diseased cell model
US8030070B2 (en) * 2004-04-28 2011-10-04 Sanofi Pasteur Vaxdesign Corp. Artificial lymphoid tissue equivalent
US7771999B2 (en) 2004-04-28 2010-08-10 Vaxdesign Corp. Disease model incorporation into an artificial immune system (AIS)
US7709256B2 (en) * 2004-04-28 2010-05-04 Vaxdesign Corp. Disease model incorporation into an artificial immune system (AIS)
US7785883B2 (en) 2004-04-28 2010-08-31 Vax Design Corp. Automatable artificial immune system (AIS)
US8071373B2 (en) 2004-04-28 2011-12-06 Sanofi Pasteur Vaxdesign Corp. Co-culture lymphoid tissue equivalent (LTE) for an artificial immune system (AIS)
US8003387B2 (en) 2005-12-21 2011-08-23 Sanofi Pasteur Vaxdesign Corp. In vitro germinal centers
JP2009521228A (ja) * 2005-12-21 2009-06-04 ヴァックスデザイン コーポレーション 単球の樹状細胞への分化を促進する多孔質膜デバイス
ATE525093T1 (de) * 2006-06-27 2011-10-15 Sanofi Pasteur Vaxdesign Corp Modelle für die bewertung von impfstoffen
US8647837B2 (en) * 2007-07-16 2014-02-11 Sanofi Pasteur Vaxdesign Corp. Artificial tissue constructs comprising alveolar cells and methods for using the same
AU2010225438A1 (en) * 2009-03-17 2011-10-13 The Heart Research Institute Ltd Method of cell differentiation and uses therefor in screening, diagnosis and therapy
US8802747B2 (en) * 2009-08-26 2014-08-12 Molecular Imprints, Inc. Nanoimprint lithography processes for forming nanoparticles
US10731129B2 (en) 2012-03-07 2020-08-04 Children's Medical Center Corporation Methods of evaluating immunogenicity of an agent using an artificial tissue construct
US9423234B2 (en) 2012-11-05 2016-08-23 The Regents Of The University Of California Mechanical phenotyping of single cells: high throughput quantitative detection and sorting
FR3045664A1 (fr) * 2015-12-17 2017-06-23 Oreal Membrane pour tissu reconstruit comprenant des pores de plusieurs diametres
AU2017325009B2 (en) * 2016-09-08 2023-07-20 Sanofi Pasteur Vaxdesign Corp. In vitro neonatal biomimetic (NMIMIC) model and methods of using same
KR101986092B1 (ko) * 2016-09-13 2019-06-05 대한뉴팜(주) 유두진피 섬유아세포의 고순도 분리 방법
KR102492455B1 (ko) * 2016-11-24 2023-01-27 알베오릭스 테크놀러지스 아게 세포 배양 시스템 및 방법
US11175282B2 (en) 2017-06-26 2021-11-16 Biohope Scientfic Solutions For Human Health S.L. Method for predicting and monitoring clinical response to immunomodulatory therapy
CN112221543B (zh) * 2019-07-15 2024-05-10 京东方科技集团股份有限公司 细胞片层转移器件、运输装置和转移细胞片层的方法

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5160490A (en) * 1986-04-18 1992-11-03 Marrow-Tech Incorporated Three-dimensional cell and tissue culture apparatus
US5720937A (en) * 1988-01-12 1998-02-24 Genentech, Inc. In vivo tumor detection assay
US5008116A (en) * 1988-11-14 1991-04-16 Frederick Cahn Immunostimulatory microsphere
US5562910A (en) * 1989-09-25 1996-10-08 University Of Utah Research Foundation Vaccine compositions and method for enhancing an immune response
US5188959A (en) * 1989-09-28 1993-02-23 Trustees Of Tufts College Extracellular matrix protein adherent t cells
US5827641A (en) * 1992-11-13 1998-10-27 Parenteau; Nancy L. In vitro cornea equivalent model
US5695996A (en) * 1994-09-23 1997-12-09 The United States Of America As Represented By The Department Of Health And Human Services Artificial organ culture system
US6479258B1 (en) * 1995-12-07 2002-11-12 Diversa Corporation Non-stochastic generation of genetic vaccines
US5739001A (en) * 1996-10-29 1998-04-14 E. I. Du Pont De Nemours And Company Solid phase cell-based assay
US6177282B1 (en) * 1997-08-12 2001-01-23 Mcintyre John A. Antigens embedded in thermoplastic
ATE428769T1 (de) * 1997-10-27 2009-05-15 Univ Rockefeller Methode und zusammensetzung zur herstellung von reifen dendritischen zellen
US6835550B1 (en) * 1998-04-15 2004-12-28 Genencor International, Inc. Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
US20020155108A1 (en) * 1998-05-04 2002-10-24 Biocrystal, Ltd. Method for ex vivo loading of antigen presenting cells with antigen, and a vaccine comprising the loaded cells
HK1046004B (en) * 1999-11-12 2013-11-08 Fibrogen, Inc. Recombinant gelatins
EP1231836A4 (en) * 1999-11-17 2004-06-02 Univ Rochester EX VIVO HUMAN IMMUNE SYSTEM
US6479064B1 (en) * 1999-12-29 2002-11-12 Children's Medical Center Corporation Culturing different cell populations on a decellularized natural biostructure for organ reconstruction
US6541225B1 (en) * 2000-01-26 2003-04-01 Raven Biotechnologies, Inc. Methods and compositions for generating human monoclonal antibodies
JP2004522446A (ja) * 2001-02-07 2004-07-29 コリア アトミック エネルギー リサーチ インスティテュート 上皮細胞の分離方法、細胞を前条件付けする方法、およびバイオ人工皮膚もしくは真皮を上皮細胞または条件付けされた細胞を用いて調製する方法
EP1437147B1 (en) * 2001-09-25 2012-06-27 National Institute for Environmental Studies Method of preparing basement membrane
FR2833271B1 (fr) * 2001-12-10 2004-09-17 Coletica Production de cellules dendritiques in vitro a partir de monocytes cd14+, pour notamment la realisation de modeles cellulaires et/ou tissulaires en suspension, en monocouches et tridimentionnels; utilisation de ces modeles
GB0130789D0 (en) * 2001-12-21 2002-02-06 King S College London Application of spores
CA2480011A1 (en) * 2002-03-18 2003-12-04 Sciperio, Inc. Dentritic cell nodes
EP2322928A1 (en) * 2002-04-11 2011-05-18 Cyclex, Inc. Method for monitoring the immune response and predicting clinical outcomes in transplant recipients using ATP measurement in lymphocytes
US20040009943A1 (en) * 2002-05-10 2004-01-15 Inex Pharmaceuticals Corporation Pathogen vaccines and methods for using the same
US20050191743A1 (en) * 2002-10-03 2005-09-01 Wu J.H. D. Three-dimensional peripheral lymphoid organ cell cultures
US20040109876A1 (en) * 2002-11-25 2004-06-10 Kureha Chemical Industry Co., Ltd. Vaccine composition, HIV-infection suppression factor and method for the vaccination against HIV
US7785806B2 (en) * 2004-04-28 2010-08-31 Vaxdesign Corporation Method for determining the immunogenicity of an antigen
US8030070B2 (en) * 2004-04-28 2011-10-04 Sanofi Pasteur Vaxdesign Corp. Artificial lymphoid tissue equivalent
US8071373B2 (en) * 2004-04-28 2011-12-06 Sanofi Pasteur Vaxdesign Corp. Co-culture lymphoid tissue equivalent (LTE) for an artificial immune system (AIS)
WO2005104755A2 (en) * 2004-04-28 2005-11-10 Vaxdesign Corporation Artificial immune system: methods for making and use
US7855074B2 (en) * 2004-04-28 2010-12-21 Vaxdesign Corp. Artificial immune system: methods for making and use
US20070141552A1 (en) * 2004-04-28 2007-06-21 Warren William L Automatable artificial immune system (AIS)
US20060275270A1 (en) * 2004-04-28 2006-12-07 Warren William L In vitro mucosal tissue equivalent
US7771999B2 (en) * 2004-04-28 2010-08-10 Vaxdesign Corp. Disease model incorporation into an artificial immune system (AIS)
US7785883B2 (en) * 2004-04-28 2010-08-31 Vax Design Corp. Automatable artificial immune system (AIS)
JP2009521228A (ja) * 2005-12-21 2009-06-04 ヴァックスデザイン コーポレーション 単球の樹状細胞への分化を促進する多孔質膜デバイス
US8003387B2 (en) * 2005-12-21 2011-08-23 Sanofi Pasteur Vaxdesign Corp. In vitro germinal centers
ATE525093T1 (de) * 2006-06-27 2011-10-15 Sanofi Pasteur Vaxdesign Corp Modelle für die bewertung von impfstoffen
CA2692689A1 (en) * 2007-07-06 2009-01-15 Vaxdesign Corporation Rapid generation of t cell-independent antibody responses to t cell-dependent antigens

Similar Documents

Publication Publication Date Title
JP2009521228A5 (enExample)
CN102911918B (zh) 一种基因工程细胞及其在nk细胞扩增中的应用
JP5614471B2 (ja) 寸法が保持された細胞シート、その製造方法、及びそのための細胞培養担体
JP6733126B2 (ja) 三次元細胞集合体の作製方法
WO2007146267A3 (en) Disease model incorporation into an artificial immune system (ais)
JP2007537732A5 (enExample)
DE602004030273D1 (de) Menschliche hornhautendothelzellen und verfahren zur gewinnung und kultivierung von zellen zur hornhautzelltransplantation
JP2010161952A (ja) 生体組織の作製方法
Kim et al. Cell sheet tissue engineering for scaffold-free three-dimensional (3D) tissue reconstruction
US12264308B2 (en) System and methods for immune cells expansion and activation in large scale
JP6047000B2 (ja) 細胞を含む支持体層に培養液を灌流させることを特徴とする３次元培養組織
Cushing et al. Serum deprivation improves seeding and repopulation of acellular matrices with valvular interstitial cells
CN211999724U (zh) 一种自体脂肪干细胞制剂离心培养制备装置
JP6029102B2 (ja) 三次元培養弾性線維組織の製造方法
Musey et al. Development of artificial blood vessels: seeding and proliferation characteristics of endothelial and smooth muscle cells on biodegradable membranes
JP2014023540A (ja) 生体組織の作製方法
JP2018108038A (ja) 細胞培養担体
CN103923832B (zh) 一种细胞拆分装置和细胞拆分方法
CN115233315A (zh) 一种细胞库的构建方法、细胞库及细胞产品
CN203754727U (zh) 一种用于毛囊培养的装置
JP2004344002A (ja) 多孔膜を用いた細胞培養方法
Burton et al. A 3D Printed Bioreactor with Electrospun Scaffold as a Millifluidic Renal Tubule Model
Luna Biomimetic Components Aiming to Improve in vitro Cardiac Culture Systems as Building Blocks to Reshape Failing Hearts
Stich et al. S 1-11: Live Cell Micromanipulation and Capture using the Laser MicroBeam
Shen et al. Effects of Enzymes Treatment on Structure and Properties of Acellular Dermal Matrix